Publicacións nas que colabora con Maria Melendo Viu (33)

2024

  1. Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’ [American Journal of Cardiology 206 (2023) 320-329, (S000291492300766X), (10.1016/j.amjcard.2023.08.010)]

    American Journal of Cardiology

  2. Hypertrophic cardiomyopathy: New pathogenic variant in MYH7

    Medicina Clinica

2023

  1. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis

    Trends in Cardiovascular Medicine, Vol. 33, Núm. 5, pp. 319-326

  2. Bleeding and embolic risk in patients with atrial fibrillation and cancer

    Revista Espanola de Cardiologia, Vol. 76, Núm. 5, pp. 344-352

  3. Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score

    American Journal of Cardiology, Vol. 206, pp. 320-329

  4. Heart failure in older patients with atrial fibrillation: incidence and risk factors

    Revista Espanola de Cardiologia

  5. Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881

  6. Home exercise intervention with the Vivifrail program in frail older patients with heart failure with reduced ejection fraction. The ExFRAIL-HF randomized trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 939-943

  7. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  8. Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry

    Journal of the American Heart Association, Vol. 12, Núm. 15, pp. e028475

  9. IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry

    International Journal of Cardiology, Vol. 370, pp. 35-42

  10. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204

  11. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

    Life, Vol. 13, Núm. 4

2022

  1. Acute heart failure in a kidney transplant patient

    Kidney International, Vol. 102, Núm. 1, pp. 211

  2. Applicability of the Academic Research Consortium for High Bleeding Risk in acute coronary syndrome undergoing percutaneous coronary intervention

    Revista Espanola de Cardiologia, Vol. 75, Núm. 5, pp. 375-383

  3. Incidence and Predictors of Bleeding in Patients With Cancer and Atrial Fibrillation

    American Journal of Cardiology, Vol. 167, pp. 139-146

  4. Ischemic-hemorrhagic balance in diabetic and non-diabetic patients after acute coronary syndrome

    REC: CardioClinics, Vol. 57, Núm. 3, pp. 203-211

  5. Nutrition status, obesity and outcomes in patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 826-833

  6. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  7. Trade-off between the effects of embolic versus bleeding events on mortality in elderly patients with atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 75, Núm. 4, pp. 334-342